379 related articles for article (PubMed ID: 22745325)
1. Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice.
Parsa R; Andresen P; Gillett A; Mia S; Zhang XM; Mayans S; Holmberg D; Harris RA
Diabetes; 2012 Nov; 61(11):2881-92. PubMed ID: 22745325
[TBL] [Abstract][Full Text] [Related]
2. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
Christianson SW; Shultz LD; Leiter EH
Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
[TBL] [Abstract][Full Text] [Related]
3. Protection against autoimmune diabetes with oral insulin is associated with the presence of IL-4 type 2 T-cells in the pancreas and pancreatic lymph nodes.
Ploix C; Bergerot I; Fabien N; Perche S; Moulin V; Thivolet C
Diabetes; 1998 Jan; 47(1):39-44. PubMed ID: 9421372
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 gene transfer into insulin-producing β cells protects against diabetes in non-obese diabetic mice.
Xu A; Zhu W; Li T; Li X; Cheng J; Li C; Yi P; Liu L
Mol Med Rep; 2015 Sep; 12(3):3881-3889. PubMed ID: 25998958
[TBL] [Abstract][Full Text] [Related]
5. Artesunate prevents type 1 diabetes in NOD mice mainly by inducing protective IL-4-producing T cells and regulatory T cells.
Li Z; Shi X; Liu J; Shao F; Huang G; Zhou Z; Zheng P
FASEB J; 2019 Jul; 33(7):8241-8248. PubMed ID: 30916998
[TBL] [Abstract][Full Text] [Related]
6. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
Hancock WW; Polanski M; Zhang J; Blogg N; Weiner HL
Am J Pathol; 1995 Nov; 147(5):1193-9. PubMed ID: 7485382
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.
Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A
J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799
[TBL] [Abstract][Full Text] [Related]
8. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
9. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells.
Madec AM; Mallone R; Afonso G; Abou Mrad E; Mesnier A; Eljaafari A; Thivolet C
Diabetologia; 2009 Jul; 52(7):1391-9. PubMed ID: 19421731
[TBL] [Abstract][Full Text] [Related]
11. β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice.
Manzoor F; Johnson MC; Li C; Samulski RJ; Wang B; Tisch R
Eur J Immunol; 2017 Jan; 47(1):144-154. PubMed ID: 27859048
[TBL] [Abstract][Full Text] [Related]
12. IL-7 uniquely maintains FoxP3(+) adaptive Treg cells that reverse diabetes in NOD mice via integrin-β7-dependent localization.
Li CR; Deiro MF; Godebu E; Bradley LM
J Autoimmun; 2011 Nov; 37(3):217-27. PubMed ID: 21745722
[TBL] [Abstract][Full Text] [Related]
13. Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice.
Creusot RJ; Yaghoubi SS; Kodama K; Dang DN; Dang VH; Breckpot K; Thielemans K; Gambhir SS; Fathman CG
Clin Immunol; 2008 May; 127(2):176-87. PubMed ID: 18337172
[TBL] [Abstract][Full Text] [Related]
14. Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.
Yang W; Hussain S; Mi QS; Santamaria P; Delovitch TL
J Immunol; 2004 Oct; 173(7):4407-16. PubMed ID: 15383571
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D supplementation induces CatG-mediated CD4
Lai X; Liu X; Cai X; Zou F
Am J Physiol Endocrinol Metab; 2022 Jan; 322(1):E74-E84. PubMed ID: 34779254
[TBL] [Abstract][Full Text] [Related]
16. Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-gamma in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells.
Reddy S; Karanam M; Krissansen G; Nitschke K; Neve J; Poole CA; Ross JM
Histochem J; 2000 Apr; 32(4):195-206. PubMed ID: 10872884
[TBL] [Abstract][Full Text] [Related]
17. AAV8-mediated gene transfer of interleukin-4 to endogenous beta-cells prevents the onset of diabetes in NOD mice.
Rehman KK; Trucco M; Wang Z; Xiao X; Robbins PD
Mol Ther; 2008 Aug; 16(8):1409-16. PubMed ID: 18560422
[TBL] [Abstract][Full Text] [Related]
18. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.
Mukherjee R; Chaturvedi P; Qin HY; Singh B
J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-Associated Inflammatory Changes in the Pre-Diabetic Pancreas of Early-Age NOD Mice.
Garciafigueroa Y; Phillips BE; Engman C; Trucco M; Giannoukakis N
Front Endocrinol (Lausanne); 2021; 12():565981. PubMed ID: 33776903
[TBL] [Abstract][Full Text] [Related]
20. Suppression of autoimmune diabetes by soluble galectin-1.
Perone MJ; Bertera S; Shufesky WJ; Divito SJ; Montecalvo A; Mathers AR; Larregina AT; Pang M; Seth N; Wucherpfennig KW; Trucco M; Baum LG; Morelli AE
J Immunol; 2009 Mar; 182(5):2641-53. PubMed ID: 19234158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]